$218 Million is the total value of HealthInvest Partners AB's 18 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 44.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ANIK | Sell | ANIKA THERAPEUTICS INC | $22,135,000 | +0.9% | 412,588 | -15.9% | 10.15% | -1.1% |
| GNCIQ | Buy | GNC HLDGS INC | $16,565,000 | -11.1% | 681,955 | +16.2% | 7.60% | -12.9% |
| AMAG | Sell | AMAG PHARMACEUTICALS INC | $16,064,000 | -7.3% | 671,585 | -9.3% | 7.37% | -9.2% |
| SUPN | Sell | SUPERNUS PHARMACEUTICALS INC | $13,394,000 | -2.8% | 657,533 | -27.2% | 6.14% | -4.8% |
| GTS | Buy | TRIPLE-S MGMT CORPcl b | $13,018,000 | +3.9% | 532,876 | +5.8% | 5.97% | +1.8% |
| MRK | Sell | MERCK & CO INC | $12,910,000 | -2.9% | 224,100 | -10.9% | 5.92% | -4.9% |
| ABC | New | AMERISOURCEBERGEN CORP | $12,691,000 | – | 160,000 | +100.0% | 5.82% | – |
| FEIC | Sell | FEI CO | $12,677,000 | -40.6% | 118,609 | -50.5% | 5.81% | -41.8% |
| TARO | Sell | TARO PHARMACEUTICAL INDS LTD | $12,551,000 | -6.8% | 86,205 | -8.3% | 5.76% | -8.7% |
| CAH | New | CARDINAL HEALTH INC | $12,482,000 | – | 160,000 | +100.0% | 5.72% | – |
| CRL | Sell | CHARLES RIV LABS INTL INC | $12,334,000 | -8.9% | 149,612 | -16.1% | 5.66% | -10.8% |
| ANTM | ANTHEM INC | $12,333,000 | -5.5% | 93,900 | 0.0% | 5.66% | -7.5% | |
| LPNT | Sell | LIFEPOINT HEALTH INC | $12,149,000 | -36.1% | 185,851 | -32.3% | 5.57% | -37.4% |
| CXRXF | New | CONCORDIA INTL CORP | $11,696,000 | – | 543,000 | +100.0% | 5.36% | – |
| INCR | Sell | INC RESH HLDGS INCcl a | $10,915,000 | -18.3% | 286,270 | -11.7% | 5.00% | -20.0% |
| INSYQ | New | INSYS THERAPEUTICS INC NEW | $10,199,000 | – | 788,175 | +100.0% | 4.68% | – |
| OSUR | Buy | ORASURE TECHNOLOGIES INC | $2,812,000 | -4.2% | 475,771 | +17.3% | 1.29% | -6.2% |
| ICCC | IMMUCELL CORP | $1,161,000 | +0.7% | 168,323 | 0.0% | 0.53% | -1.5% | |
| SCLN | Exit | SCICLONE PHARMACEUTICALS INC | $0 | – | -236,288 | -100.0% | -1.22% | – |
| DEPO | Exit | DEPOMED INC | $0 | – | -200,000 | -100.0% | -1.30% | – |
| SSRG | Exit | SYMMETRY SURGICAL INC | $0 | – | -316,427 | -100.0% | -1.46% | – |
| VRX | Exit | VALEANT PHARMACEUTICALS INTL | $0 | – | -370,000 | -100.0% | -4.56% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-07-26
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CHARLES RIV LABS INTL INC | 17 | Q4 2017 | 12.8% |
| GILEAD SCIENCES INC | 16 | Q4 2022 | 14.5% |
| CARDINAL HEALTH INC | 15 | Q4 2022 | 14.8% |
| IMMUCELL CORP | 15 | Q2 2017 | 1.7% |
| MCKESSON CORP | 14 | Q3 2022 | 14.6% |
| ANTHEM INC | 12 | Q4 2017 | 14.3% |
| TRIPLE-S MGMT CORP | 12 | Q4 2016 | 8.7% |
| LIFEPOINT HOSPITALS INC | 11 | Q2 2016 | 13.3% |
| SUPERNUS PHARMACEUTICALS INC | 10 | Q3 2021 | 15.5% |
| ANIKA THERAPEUTICS INC | 10 | Q4 2017 | 13.0% |
View HealthInvest Partners AB's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| NOVAMED INC | March 03, 2011 | 405,875 | 5.1% |
| THERAGENICS CORP | February 11, 2009 | 3,322,846 | 9.9% |
| BIO IMAGING TECHNOLOGIES INC | January 09, 2009 | 766,425 | 5.3% |
| ALLION HEALTHCARE INC | July 07, 2008 | 887,255 | 4.6% |
| SONIC INNOVATIONS INC | June 26, 2008 | 1,328,201 | 4.9% |
| CANDELA CORP /DE/ | June 06, 2008 | 697,164 | 3.1% |
| INTEGRAMED AMERICA INC | June 02, 2008 | 2,200 | 0.0% |
| AFP IMAGING CORP | February 04, 2008 | 27,520 | 0.2% |
| OPHTHALMIC IMAGING SYSTEMS | December 28, 2007 | 834,440 | 4.9% |
| ANGEION CORP/MN | October 16, 2007 | 196,024 | 4.8% |
View HealthInvest Partners AB's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-25 |
| 13F-HR | 2024-01-30 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-10-21 |
| 13F-HR | 2022-07-08 |
| 13F-HR | 2022-05-05 |
| 13F-HR | 2022-01-18 |
| 13F-HR | 2021-11-08 |
| 13F-HR | 2021-08-10 |
| 13F-HR | 2021-04-30 |
View HealthInvest Partners AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.